These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12725142)

  • 1. Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    Wardi J; Shirin H
    Isr Med Assoc J; 2003 Mar; 5(3):195-7. PubMed ID: 12725142
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori, GERD, NSAIDs, and cancer: where we really stand.
    Graham DY
    Am J Gastroenterol; 1999 May; 94(5):1420-1. PubMed ID: 10235238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 4. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].
    Lesur G
    Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].
    Bretagne JF; Pagenault M; Bourienne A; Heresbach D
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C48-64. PubMed ID: 10880915
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptic ulcer disease.
    Harbison SP; Dempsey DT
    Curr Probl Surg; 2005 Jun; 42(6):346-454. PubMed ID: 15988415
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs (NSAIDs) cause gastrointestinal intolerance and major bleeding--or do they?
    Tenenbaum J
    Clin Invest Med; 1987 May; 10(3):246-50. PubMed ID: 3304753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs.
    McCarthy DM
    Scand J Gastroenterol Suppl; 1991; 187():91-7. PubMed ID: 1775931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
    Cryer B
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S407-11. PubMed ID: 11570034
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-induced ulcers.
    Go MF
    Acta Gastroenterol Latinoam; 1996; 26(2):115-8. PubMed ID: 9137667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.